Peptide University · 4 lessons · 32 min

Module 5: The somatotropic axis: growth hormone secretagogues

Physiology of the GH/IGF-1 axis and its pulsatility, and the differentiated pharmacology of GHRH analogs and GHRPs/ghrelin mimetics, with their rational synergy.

This is module 5 of the NeoPeptidos Professional Certification in Peptide Science. It has 4 lessons; each one can be read on its own and all of them are part of the syllabus assessed at the end of the module.

Lesson 1. Physiology of the GH/IGF-1 axis

Growth hormone (GH) is secreted by the anterior pituitary under dual hypothalamic control: GHRH stimulates it and somatostatin restrains it. A third axis, ghrelin (from the stomach), enhances release through the growth hormone secretagogue receptor GHS-R.

Read the lesson →

Lesson 2. GHRH analogs

GHRH analogs act on the GHRH receptor in the pituitary, mimicking the stimulatory hypothalamic signal. They differ mainly in their pharmacokinetics:

Read the lesson →

Lesson 3. GHRPs, ghrelin mimetics and synergy

The second class of secretagogues acts on the GHS-R receptor (the ghrelin receptor), through a pathway different from GHRH's:

Read the lesson →

Lesson 4. IGF-1, its binding proteins and its variants

Most of the anabolic effects attributed to growth hormone are not produced by GH directly but by IGF-1, synthesized mainly in the liver under GH stimulation. Understanding IGF-1 is understanding half of the somatotropic axis.

Read the lesson →

Module quiz

When you finish the lessons, take the quiz on the course page. Your progress is saved to your account.

Go to the quiz →

Educational content for scientific purposes. It distinguishes preclinical from clinical evidence and is not medical advice, diagnosis or a recommendation for use. NeoPeptidos products are sold labelled for research use only (RUO).